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Abstract
Background: The inability to analyze gene expression in living neurons from Angelman (AS) and Duplication 15q
(Dup15q) syndrome subjects has limited our understanding of these disorders at the molecular level.
Method: Here, we use dental pulp stem cells (DPSC) from AS deletion, 15q Duplication, and neurotypical control
subjects for whole transcriptome analysis. We identified 20 genes unique to AS neurons, 120 genes unique to 15q
duplication, and 3 shared transcripts that were differentially expressed in DPSC neurons vs controls.
Results: Copy number correlated with gene expression for most genes across the 15q11.2-q13.1 critical region. Two
thirds of the genes differentially expressed in 15q duplication neurons were downregulated compared to controls
including several transcription factors, while in AS differential expression was restricted primarily to the 15q region.
Here, we show significant downregulation of the transcription factors FOXO1 and HAND2 in neurons from 15q
duplication, but not AS deletion subjects suggesting that disruptions in transcriptional regulation may be a driving
factor in the autism phenotype in Dup15q syndrome. Downstream analysis revealed downregulation of the ASD
associated genes EHPB2 and RORA, both genes with FOXO1 binding sites. Genes upregulated in either Dup15q
cortex or idiopathic ASD cortex both overlapped significantly with the most upregulated genes in Dup15q DPSC-
derived neurons.
Conclusions: Finding a significant increase in both HERC2 and UBE3A in Dup15q neurons and significant decrease
in these two genes in AS deletion neurons may explain differences between AS deletion class and UBE3A specific
classes of AS mutation where HERC2 is expressed at normal levels. Also, we identified an enrichment for FOXO1-
regulated transcripts in Dup15q neurons including ASD-associated genes EHPB2 and RORA indicating a possible
connection between this syndromic form of ASD and idiopathic cases.
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Background
The study of neurogenetic syndromes in the laboratory
setting is inherently complicated by a lack of easy access
to living neurons for gene expression and electrophysio-
logical studies. Although a variety of stem cell types has
been used in the laboratory, including embryonic stem
cells, blood stem cells, and most notably induced
pluripotent stem cells (iPSCs) derived from skin biopsies
[1], there are still technical issues complicating the use
of these limited resources. As an alternative to iPSC,
dental pulp stem cells (DPSC) are neural crest-derived
multipotent cells that can be easily obtained from deep
within the pulp of shed (deciduous) teeth that either fall
out on their own or are extracted in the pediatric clinic
setting when ready for exfoliation. DPSC have been dif-
ferentiated into a variety of cell types including osteo-
blasts, hepatocytes, insulin-producing cells, and even
neurons [2]. Furthermore, neurons derived from DPSC
display action potentials (Na+ currents) [3, 4] and are
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positive for neuronal markers like MAP2 and TUJ1 [5]. In
our hands, DPSC-derived neurons have not been able to
survive in vitro long enough to become mature neurons
unless they are first immortalized. We are confident, how-
ever, that these immature neuronal cultures are an excel-
lent resource for gene expression studies in the disease
state, especially for neurodevelopmental disorders where
the phenotypes appear at or near birth. In addition, we re-
cently showed that DPSC maintain an epigenetic land-
scape more similar to embryonic stem cells than iPSC
making them ideal for gene expression studies [6]. DPSC
can also be easily made into neurons without the use of
viral vectors. Finally, the collection of DPSC from individ-
uals with these syndromes is quite easy and non-invasive.
Sample collection can even take place through shipments
of exfoliated teeth by parents from remote locations where
the subjects reside.
Recently, our laboratory performed an extensive mo-
lecular characterization of both DPSC and DPSC-
derived neuronal cultures [5]. We established that the
process of differentiation from DPSC to neurons is pri-
marily driven by the downregulation of the REST tran-
scriptional repressor, turning on a number of genes
involved in neuronal differentiation and function produ-
cing cells that show a strong induction of the neuron-
specific MAP2 marker and residual expression of glial
marker GFAP indicating that these cultures are repre-
sentative of the mixed neuron/glia characteristics of the
human brain [5].
Here, we provide compelling evidence that DPSC neur-
onal cultures can be used for the molecular investigation
of neurons in the disease state by analyzing gene expres-
sion in DPSC neuronal cultures from two distinct, but
molecularly related, syndromes. We focused this study on
two reciprocal genomic disorders: duplication of proximal
15q11.2-q13.1 (Dup 15q syndrome MIM: 608636) result-
ing in one of the most common forms of autism with an
identifiable molecular lesion [7–10] and Angelman syn-
drome (AS MIM: 105830) which is caused, in ~ 75–80%
of cases [11], by a deletion of this same critical region of
~ 5Mb on chromosome 15q11.2-q13.1 (Fig. 1).
While it is apparent that the key components of the
Angelman syndrome phenotype are caused by loss of
function of the maternally expressed UBE3A gene in the
brain [12, 13], it is still unclear how loss of UBE3A can
directly lead to the observed neurological defects includ-
ing synaptic plasticity problems, ataxia, seizures, and intel-
lectual disability [14]. Significant effort has surrounded
the search for direct targets of the UBE3A ubiquitin ligase
in model systems from flies to mice [15–20]. However, lit-
tle progress has been made in identifying a single sub-
strate or even pathway that can explain the plasticity,
motor, and learning/memory deficits in these animal
models. One aspect of UBE3A function that has largely
been ignored is the observation that UBE3A can act as a
transcriptional regulator in addition to its role as a ubiqui-
tin ligase [21, 22].
Almost nothing is known about the underlying patho-
genesis of Duplication 15q syndrome, caused by intersti-
tial and isodicentric duplications of 15q11.2-q13.1 that
may involve several genes in the duplicated region to
produce the autism spectrum disorder (ASD) and
Fig. 1 FISH confirmation of duplication/deletion boundaries. The colored circles on the top of the figure represent FISH probes for NIPA1 (red),
SNRPN (green), and TRPM1 (red). These probes were used to determine the duplication/deletion status for all cell lines and to establish if these
duplications/deletions included BP1-BP2 and or BP4-BP5 genes. Signals for AS deletion TP-078 (NIPA1 and SNRPN) indicate a deletion only of the
BP2-BP3 region on one allele; signals for the control TP-037 line (NIPA1 and SNRPN) indicate two copies of the BP1-BP3 region; and signals for
idic(15) TP-058 (TRPM1 and SNRPN) indicate the presence of four copies of BP2-BP3 as well as BP4-BP5
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seizure phenotypes found in patients with this disorder
[7, 10, 23]. Some studies have indicated that the mater-
nally expressed UBE3A gene may be a major contributor
to the autism phenotype in these individuals since in
both interstitial and isodicentric duplications, there is a
clear bias towards maternally derived or inherited dupli-
cations where ASD is present [24–26]. Some evidence
also suggests that the seizure phenotype in these individ-
uals may be related to over-expression of a GABA (A)
receptor subunit gene cluster also located in the critical
BP2-BP3 duplicated region [7]. However, it has been dif-
ficult to definitively establish that the GABA receptor
genes are indeed elevated in 15q Duplication post-
mortem brain tissue [27, 28] or blood [29]. The contri-
bution of other genes, both within the duplicated region
and elsewhere in the genome, to the 15q Duplication
syndrome phenotype is almost entirely speculative at
this time since no comprehensive analysis of gene
expression from Duplication 15q patient neurons is
currently available.
In this study, we interrogated genome-wide gene ex-
pression changes in DPSC and DPSC neuronal cultures
from individuals with both AS deletions and 15q dupli-
cations in an effort to establish which gene networks
may be involved in the phenotypes of these two syn-
dromes, but also to directly compare the consequences
on gene expression for duplication/deletion of the same
chromosomal region that ties these two disorders at the
genomic level. Whole genome gene expression analysis
of patient-derived DPSC neuronal cultures from these
disorders has revealed several key regulators of gene ex-
pression and neurologically relevant genes which may
substantially contribute to the 15q duplication syndrome
phenotype, while the number of gene expression changes
in the Angelman syndrome set remained quite small.
Perhaps most surprising was the extensive change ob-
served for transcription factor encoded genes in the 15q
Duplication syndrome subjects, suggesting global tran-
scriptional changes mediated by transcription factors
FOXO1 and/or HAND2 may be driving the pathogen-
esis of ASD in this syndrome.
Methods
Generation of dental pulp stem cell cultures
Control teeth were obtained through the Department of
Pediatric Dentistry at the University of Tennessee Health
Science Center (UTHSC). Teeth from AS deletion and
Dup15q subjects were shipped from various locations by
the parents of children with these conditions. The
UTHSC Institutional Review Board (IRB) approved this
study, and informed consent was obtained in accordance
with IRB policy. Immediately following extraction of a
loose tooth in the clinic, it was placed in transportation
media (DMEM/F12 50/50 mix with HEPES (Fisher
Scientific, Waltham, MA) and 100 U/mL penicillin,
100 μg/mL streptomycin). DPSC were isolated and cul-
tured as previously described with slight modifications
[30]. Briefly, the pulp was minced and digested in a solu-
tion of 3 mg/mL Collagenase type I and 4 mg/mL Dis-
pase II for 1 h at 37 °C. Cells were seeded in poly-D-
Lysine 12-well dishes and maintained under standard
conditions (37 °C, 5% CO2) in DMEM/F12 1:1, 10% fetal
bovine serum (FBS) (Fisher Scientific, Waltham, MA),
10% newborn calf serum (NCS) (Fisher Scientific,
Waltham, MA) and 100 U/mL penicillin, and 100 μg/mL
streptomycin (Pen/Strep). Sub-confluent cultures were
passaged regularly with 0.1 μM HyQTase (HyClone).
Fluorescent in situ hybridization breakpoint analysis
Fluorescent in situ hybridization was used to determine
the approximate breakpoints for either deletion or dupli-
cation DPSC lines. We used the pepsin method of
0.1 mg pepsin (Sigma-Aldrich, St. Louis, MO) in 40 ml
of 0.01N HCl in order to permeabilize the nuclear mem-
brane for access to the DNA. Three different probes lo-
calized in chromosome 15q were used: NIPA1 (BP1-
BP2) and TRPM1 (BP4-BP5) in the red spectrum and
SNRPN (BP2-BP3) in the green spectrum (SURE FISH,
Agilent, Foster City, CA). Hybridization was carried out
at RT overnight. Fluorescent signal analysis was per-
formed according to published protocols [31] using a
Leica DM6000 upright fluorescent microscope running
the Leica application Suite Imaging software (Leica
Microsystems, Wetzlar, Germany). At least 15 prepara-
tions were counted per cell line.
Neural differentiation
Early passage (2–3) primary DPSC were converted to
neurons according to a previously published protocol
[30]. 20,000 cells/cm2 were seeded in poly-D-lysine-
coated 12-well plates or T-25 flasks in DMEM/F12 (1:1),
2.5% FCS, 100 U/mL penicillin, and 100 μg/mL strepto-
mycin, and cultured for 24 h. Epigenetic reprogramming
was performed by exposing the DPSC to 10 μM 5-
azacytidine (Acros Scientific, Geel, Belgium) in DMEM/
F12 containing 2.5% FCS (Fisher Scientific, Waltham,
MA) and 10 ng/mL bFGF for 48 h. Neural differenti-
ation was induced by exposing the cells to 250 μM
IBMX, 50 μM forskolin, 200 nM TPA (Sigma Aldrich,
St. Louis, MO), 1 mM db-cAMP, 10 ng/mL bFGF,
10 ng/mL NGF (Invitrogen, Carlsbad, CA), 30 ng/mL
NT-3 (Peprotech, Rocky Hill, NJ), and 1% insulin-
transferrin-sodium selenite premix (ITS) in DMEM/F12
for 3 days. At the end of the neural induction treatment,
the cells were washed with 1X PBS. Neuronal matur-
ation was performed by maintaining the cells in Neuro-
basal A media (Invitrogen, Carlsbad, CA) supplemented
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with 1 mM dbcAMP, 1% N2, 1% B27, and 30 ng/mL
NT-3 and 1X Glutamax for 3 weeks.
RNA sequencing of DPSC and DPSC-neurons
Total RNA was extracted from ~ 3-week cultured neu-
rons and DPSC using the miRNeasy Mini kit from Qia-
gen (Foster City, CA). Total RNA was analyzed on an
Agilent Bioanalyzer 6000 pico chip and determined to
have a RIN of > 8.0. 5 ng of total RNA and was then
used to prepare dscDNA using the NuGEN Ovation V2
kit. Five hundred nanograms of this dscDNA then used
to prepare libraries for sequencing using the AB Library
Builder™ Fragment library Kit for 5500 Genetic Analysis
Systems on a Library Builder system. Libraries were
amplified 7 cycles before 5500 Wildfire primers added
by 5 cycles of fusion primer amplification as described
in the 5500 Wildfire manual (Applied Biosystems, Foster
City, CA). Before sequencing on the ABI system, small
aliquots of this material pooled and sequenced on an
Ion Torrent PGM 314 chip after additional amplification
with PGM fusion primers to estimate sample abundance.
Barcode quantification data from the PGM was used to
pool the samples with Wildfire primers equally. Follow-
ing this final pooling, the library pools were examined
and quantified on an Agilent high sensitivity DNA
chip, immobilized on flow cells for the 5500 Wildfire
instrument, and sequenced (50 bp reads) on this
instrument. On average, a total of 30 million reads
were produced per sample for downstream analysis.
Complete sequencing reads for this study are available
on the Gene Expression Omnibus (GEO) website
using query [GEO: GSE67122].
Bioinformatic analysis
ABI files were converted from XSQ format to separate
quality and colorspace fasta files for analysis using the
TopHat with Bowtie pipeline [32]. Short transcript frag-
ments were mapped to the reference human genome
(GRCh38; accession number GRCh38.77) using TopHat
v2.0.13 [33] with Bowtie v2.1.0 [34] and Samtools
v0.1.19. Mapped reads were indexed to known genes
using HTseq v0.6.1 [35]. Differentially expressed tran-
scripts were identified using the DESeq2 bioconductor
package [36]. Heatmaps were generated using the R soft-
ware package (v 3.1.1) [37]. Venn diagrams were gener-
ated online using Gene List Venn Diagram software,
additional descriptive analysis was performed using
Gene Set Enrichment Analysis (GSEA) using a rank-
ordered gene list based on fold change that was used to
identify pathways and transcription factor binding motifs
enriched in particular data sets [38]. Statistical signifi-
cance for GSEA analysis was set at q ≤ 0.25 as per the
developer’s suggestion. Gene sets were obtained from
MSigDB version 4.0. Gene sets that were found to be
significantly up- or downregulated (q ≤ 0.05) were also
analyzed as a gene list with default stringency settings
using The Database for Annotation, Visualization and
Integrated Discovery (DAVID v6.7).
Quantitative real-time PCR analysis
Total RNA was extracted from differentiated neurons
using a Direct-zol RNA miniprep plus kit (Zymogen
R0270) according to the manufacturer’s instructions and
quantified by spectrophotometry (NanoDrop Technolo-
gies). Five hundred nanograms of total RNA was used as
input for each cDNA synthesis reaction using the Tran-
scriptor First Strand cDNA Synthesis Kit (Roche,
04379012001). cDNA reactions were diluted 1:10 and
three technical replicates were performed on each sam-
ple for each gene tested using the default cycling param-
eters of the Light Cycler 480 system (Roche). For
primers and probes, see Additional file 1: Table S9. The
crossing point (Cp) value was calculated using the abso-
lute quantitation algorithm (Roche) for each sample.
Delta Cp was calculated by subtracting the GAPDH con-
trol gene Cp from the Cp of the test gene. Statistical sig-
nificance was determined by unpaired t tests corrected
for multiple comparisons.
Quantitative western blot analysis
Infrared (IR) Western blots and quantification from
DPSC neurons were performed as previously described
in Urraca et al. [5] using six unrelated DPSC lines from
neurotypical controls and idic15q. These six independ-
ent DPSC lines were not run for RNAseq analysis as
they were collected after the RNAseq runs. We used this
sample to validate the RNAseq findings in an independ-
ent cohort. The α-RORA antibody (Aviva Biosystems #
OAAN02076) was used at a dilution of 1:500 in conjunc-
tion with Li-Cor α-Rabbit 800 secondary antibody at
1:2500. Loading control was α-GAPDH with α-Goat 680
at 1:2500. Each individual sample was normalized to the
GAPDH signal as a loading control, and quantification
was performed using all 12 samples in three independent
Western blots by Student’s t test (control vs idic15).
For the analysis of neural differentiation markers, we
used three control and three idic15 lines per group. All
primary antibodies used were from AbCam (Cambridge,
MA). Primary concentrations were 1:1000 for GABAA
(ab98968), NLG1 (ab26305), PSD95 (ab12093), and
UBE3A (ab126765) and 1:2000 for MAP2 (ab5392) and
GAPDH (ab157156). Secondary IR antibodies and quan-
tification were performed as above for RORA analysis.
Comparison to postmortem Dup15q and ASD brain tissue
The most significant differentially expressed genes be-
tween control and Dup15q DPSC neurons were directly
compared to a combined list of temporal and frontal
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cortical gene expression from a study using postmortem
brain from Dup15q and ASD individuals (see [39]). This
analysis was also repeated after removing any bias from
genes in the 15q11.2-q13.1 duplicated region. We per-
formed PANTHER over-representation tests (release
20150430) on the significantly overlapping intersections
between the 1500 genes that went up most significantly
in DPSC neurons in Dup15q vs controls and the genes
that went up significantly in postmortem Dup15q cor-
tex or postmortem idiopathic ASD cortex at an FDR
of 5% [39]. These comparisons were performed using
default settings for every class of annotations, filtering
only those terms significant at a Bonferroni-corrected
p ≤ 0.05 for either of the two overlaps. The back-
ground was the intersection of genes expressed in
Parikshak et al. and genes assigned a p value by
DESeq in the current study.
Results
Identification of breakpoints in DPSC lines
Teeth used for this study were primarily obtained long
distance using a biospecimen tube filled with cell culture
media and a pre-addressed return package. As such, in
most cases, we only knew that an individual has a diag-
nosis of Angelman syndrome or 15q Duplication syn-
drome from the genetics report, which often did not
provide detailed information about critical breakpoints
for duplication/deletion in this region. The critical re-
gion for both AS and 15q Duplication syndrome con-
tains ~ 15 protein coding genes and is located between
BP2 and BP3 in Fig. 1. We performed fluorescent in situ
hybridization (FISH) analysis on DPSC cell lines from all
subjects whose samples were used for mRNA-seq ana-
lysis in order to determine if the AS deletion samples in-
cluded the BP1-BP2 region and to determine if the 15q
duplication samples were duplicated for the BP4-BP5 re-
gion. FISH signals indicated that all AS deletion samples
are deleted for the region between BP2 and BP3 on the
maternal chromosome (Table 1). The isodicentric Dupli-
cation 15q samples showed signals indicative of inclu-
sion of the BP4 to BP5 region in all cases resulting in
four copies of the entire region from BP5 to the centro-
mere in these samples (Table 1). FISH analysis of copy
number across the 15q region for all samples used in the
study is in Additional file 2: Fig. S1.
All Control DPSC showed the normal number of
signals for each probe indicating no duplications or dele-
tions in the region between BP1-BP5 in Fig. 1. AS sam-
ple TP-055 did not show a signal for probe NIPA1
indicating that this deletion is a BP1-BP3 deletion. AS
samples TP-059 and TP-078 appear to be BP2-BP3
deletions. Sample TP-041 appears to be a BP2-BP3 inter-
stitial duplication of 15q, while samples TP-044 and TP-
058 are isodicentric duplications that include four copies
of the entire BP1-BP5 region. See Additional file 2: Fig.
S1 for example FISH images.
mRNA-seq analysis of the 15q duplication/deletion critical
region
Whole genome mRNA sequencing (mRNA-seq) was
performed on nine subjects for both DPSC and DPSC
neuronal cultures with a total of 18 samples (DPSC: 3
control, 3 AS deletion, 3 15q duplication and DPSC-
neurons: 3 control, 3 AS deletion, 3 15q duplication).
DPSC lines were differentiated into neurons using previ-
ously published protocols [30], and the DPSC neuronal
cultures used for mRNA-seq studies were allowed to
mature for at least 3 weeks prior to RNA extraction.
Previous studies indicate that longer neuronal matur-
ation times (up to 10 weeks) result in significant cell
death and consequently poor RNA yield and that
massive gene expression changes have already occurred
in these cultures by ~ 3 weeks including a switch from
MAP2 negative to MAP2 positive status [5]. Based on
these studies and the potential high RNA yield, we chose
to use ≥ 3-week old DPSC neuron cultures for the
present study. Tooth samples consisted of three neuroty-
pical controls obtained locally, three AS deletion cases,
and three 15q duplication cases (one interstitial BP2-
BP3 duplication and two idic(15) cases which included
BP4-BP5) collected by the parent or guardian and
shipped to the laboratory.
In order to determine if genotype alone could explain
the variance among the cell lines, we performed
principle component analysis (PCA) across all samples
using Reads Per Kilobase of exon per Million fragments
(RPKM) mapped values as a measure of gene expression
(Fig. 2a). We found two prominent groups separated,
not by genotype, but by differentiation state (DPSC vs
DPSC-derived neurons). The undifferentiated DPSC did
not further stratify by disease state. The DPSC-derived
neurons did show some separation by gene expression
Table 1 FISH results to determine breakpoints in DPSC lines
Cell
line







TP-023 Not affected 2 copies 2 copies 2 copies
TP-037 Not affected 2 copies 2 copies 2 copies
TP-076 Not affected 2 copies 2 copies 2 copies
TP-055 AS 1 copy 1 copy 2 copies
TP-059 AS 2 copies 1 copy 2 copies
TP-078 AS 2 copies 1 copy 2 copies
TP-041 Interstitial Dup15q 2 copies 3 copies 2 copies
TP-044 idic(15) 4 copies 4 copies 3 copies
TP-058 idic(15) 4 copies 4 copies 4 copies
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with the AS deletion samples showing somewhat lower
global expression, but this observation did not reach sig-
nificance. This analysis indicates that all samples had
similar overall gene expression profiles regardless of
genotype but clearly dependent on differentiation state
from DPSC to neuronal cultures.
Next, we looked carefully at gene expression for genes
located within the duplicated or deleted region as com-
pared to neurotypical controls. A heatmap of the average
gene expression across the three lines per group for pro-
tein coding genes across the proximal 15q region from
the centromere to BP5 revealed that gene expression is
elevated at multiple loci in the Dup15q samples as
compared to neurotypical controls in both DPSC and
DPSC-derived neurons (Fig. 2b). The AS deletion lines
did not differ significantly in gene expression as com-
pared to neurotypical controls for either DPSC or
DPSC-derived neurons with a few notable exceptions:
UBE3A expression levels followed copy number in both
DPSC and neurons going up in 15q duplication and
down in AS deletion; the GABA A receptor gene cluster
consisting of GABRB3, GABRG3, and GABRA5 each
showed significantly elevated gene expression in 15q du-
plication neural cultures but were also slightly elevated
in AS deletion samples; and the HERC2 gene located at
the distal breakpoint for the AS deletion (BP3) also
a b
c d
Fig. 2 Gene expression changes across the 15q region. a principle component analysis. Note that the main differentiating feature of the gene
expression data is the cell type (i.e., DPSC or DPSC-neuron) and not the genotype of the line. b Heatmap of gene expression for genes between
BP1-BP3 on 15q11.2-q13.1. Note that some, but not all, genes show elevated expression in the DPSC and DPSC neuronal cultures from duplication
lines. The expression differences are less striking for AS deletion lines where only a few specific genes appear significantly downregulated in DPSC
and fewer still in the DPSC-neurons. c Graphs of copy number vs gene expression for DPSC in BP2-BP3 protein coding genes. Green dots are AS
deletion, red dots are typical control, blue dot is interstitial Dup15q, and light blue dots are idic(15). Note that only NIPA2, UBE3A, HERC2, and
MTMR10 showed a significant correlation between copy number and gene expression. Star indicates that these genes showed a significant trend
using Jonckheere’s trend test. d Graphs of copy number vs gene expression in neurons for the BP2-BP3 region. Note that only UBE3A and HERC2
still show a significant trend test
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showed significantly elevated gene expression in 15q du-
plication neural cultures and was significantly decreased
in AS deletion cultures (Fig. 2c).
Next, we mapped normalized gene expression (nor-
malized to controls) vs copy number for genes in the
15q region. Jonckheere’s trend tests were used to test the
hypothesis that the median gene expression of all genes
in the 15q region increases significantly as the copy
number increases. Both DPSC and DPSC-derived neu-
rons showed a significant trend with respect to copy
number (p value ≤ 1 × 10−4) indicating that as copy num-
ber increased, so did gene expression for genes in the
15q region. Several genes followed this trend of copy
number vs gene expression within the BP2-BP3 region
shared by both the AS deletion and 15q duplication
samples in both DPSC and DPSC-derived neurons (Fig.
2d). These genes included UBE3A and HERC2 which
were both significantly trending upward with copy num-
ber in both DPSC and DPSC-derived neurons (Table 2).
Genes located just outside of the PWS/AS critical region
but near the flanking breakpoints also showed a correl-
ation between copy number and gene expression, but
only for the 15q duplication samples since these AS de-
letion lines were only deleted between BP2-BP3 and
therefore have 2X copies of the regions outside of the
BP2-BP3. On the proximal side of the BP2-BP3 region,
the CYFIP1, NIPA1, NIPA2, and TUBGC5 genes all
showed elevated expression in 15q duplication samples
consistent with increased copy number (4X) for these
genes in 15q duplication samples. On the distal side of
the PWS/AS, there was a notable change in CHNRA7
gene expression from inverse correlation in DPSC to
correlated copy number and gene expression in DPSC
neuronal cultures (Fig. 2d). Overall there was a positive
correlation between DNA copy number and gene ex-
pression in the 15q region in both DPSC and DPSC-
derived neurons.
Gene expression in AS and 15q duplication compared to
controls
Global protein coding mRNA gene expression was com-
pared between AS deletion and typical controls as well
as 15q duplication and neurotypical controls for both
DPSC and DPSC-derived neurons using DEseq to assess
fold change and significantly differential whole transcript
level expression [40]. Only 13 genes were found to be
significantly different in AS deletion subjects and 7
genes in 15q duplication vs controls for the undifferenti-
ated DPSC at an adjusted p value ≤ 0.05. None of these
20 genes was shared between the two disease states.
After differentiation into neurons, 123 genes were sig-
nificantly different (adj. p value ≤ 0.05) in the 15q dupli-
cation samples vs control and 23 genes in the AS
deletion samples (adj. p value ≤ 0.05). Two of these
genes, DPT and AKRIC1, were elevated in both 15q du-
plication and AS deletion samples (Fc = + 2.8) while
MED12L gene expression decreased (Fc = − 2.8) in both
groups. None of these genes was located in the PWS/AS
critical region. Boxplots of all significantly different
genes discussed in the text that are not located in the
15q11.2-q13.1 critical region can be found in Additional
file 2: Fig. S2. However, when gene expression was com-
pared between 15q duplication and AS deletion samples
(both DPSC and DPSC-derived neurons), there were sig-
nificant differences in gene expression for several genes
in the 15q region. In DPSC NIPA2, UBE3A, HERC2, and
ATP10A, all showed significant increase in gene expres-
sion (adj. p value ≤ 0.05) in 15q duplication cells vs AS
deletion cells with a fold change ranging from 2.3–3.7.
In DPSC-derived neurons, six genes (NIPA2, UBE3A,
HERC2, NDNL2, CYFIP1, TUBGCP5) showed signifi-
cantly higher expression in 15q duplication neurons (adj.
p value ≤ 0.05) with a fold change ranging from 2.3–3.7
depending on the gene. Perhaps, the most interesting
genes differentially regulated in the 15q duplication
neurons were the CCL7 gene, a chemokine associated
with autoimmune response (adj. p value = 2 × 10−3; logFc
= + 2.0), and the two transcription factor genes FOXO1,
also known as FOXO1A (adj-pvalue = 3X10
−3; Fc = − 3.4), a
transcription factor that functions in the AKT signaling
cascade and HAND2 (adj. p value = 2.4 × 10−5; Fc = − 6.5).
HAND2 plays a role in the development of the sympa-
thetic nervous system and could be involved in several
Dup15q phenotypes [41–43]. In the AS deletion neurons,
Table 2 Jonckheere trend test for correlation between copy
number and gene expression
Genes DPSC Neurons
p value adj. p p value adj. p
TUBGCP5 0.057 0.105 0.140 0.224
NIPA1 0.021 0.066 0.139 0.224
CYFIP1 0.065 0.105 0.033 0.172
NIPA2 0.005 0.021 0.058 0.172
NDN 0.582 0.582 0.580 0.623
UBE3A 4.00E-04 0.006 0.002 0.014
ATP10A 0.194 0.239 0.495 0.609
GABRB3 0.336 0.384 0.139 0.224
GABRG3 0.060 0.105 0.195 0.284
HERC2 0.004 0.021 0.001 0.014
APBA2 0.094 0.126 0.059 0.172
NDNL2 0.062 0.105 0.065 0.172
TJP1 0.093 0.126 0.096 0.220
MTMR10 0.004 0.021 0.338 0.450
CHRNA7 0.481 0.513 0.584 0.623
GREM1 0.036 0.096 0.745 0.745
Urraca et al. Molecular Autism  (2018) 9:6 Page 7 of 16
the most interesting single genes that changed were
SHISH2 (adj. p value = 3.5 × 10−6; Fc = − 4.9), an antag-
onist to both WNT and FGF signaling pathways, and
TRHDE (adj. p value = 3 × 10−4; Fc = + 5.7) an extracel-
lular peptidase that cleaves neuropeptide thyrotropin-
releasing hormone and CRY2 (adj. p value = 2 × 10−2; Fc
= − 2.0). CRY2 is a circadian clock gene, and circadian
rhythm defects have been found in both fly and mouse
models of AS [44, 45].
Unsupervised cluster analysis revealed underlying gene
expression signatures of differentially regulated gene sets
indicating that for the 15q duplication samples, there is
significant downregulation of 2/3 of the differentially
expressed genes and upregulation for about 1/3 of the
genes identified compared to neurotypical controls. No
obvious pattern was identified in either DPSC or DPSC
neuronal cultures for AS deletion samples (Fig. 3a).
When we compared 15q duplication to AS deletion sam-
ples, there was an inverse relationship for 285 genes that
are differentially regulated between 15q duplication and
AS deletion neurons (adj. p value ≤ 0.05). As expected,
five of these differentially regulated genes were in the
duplicated/deleted region (CYFIP1, UBE3A, HERC2,
NIPA1, and TUBGCP5). However, another 51 genes
were differentially expressed between 15q duplication
and neurotypical control samples as well. These results
indicate that for almost half of the genes determined to
show increased/decreased expression in DPSC neuronal
cultures (120), the expression signature between AS de-
letion and neurotypical controls was not significantly
different. In addition, these changes in gene expression
are not just for genes within the duplicated region, but
our results show significant changes in gene expression
for genes outside of the 15q11.2-q13.1 region as well in
15q duplication neuronal cultures.
We tested the null hypothesis that the gene expression
trends observed were random or independent of the dis-
ease state (i.e., control vs Dup15q vs AS). In both cases,
chi-squared testing revealed that the downregulation of
gene expression is significant in 15q duplication neuron
cultures. Of the 123 genes differentially expressed in the
15q duplication disease state vs control, 44 genes were
upregulated and 79 genes were downregulated. A chi-
squared fit test revealed that the number of up- and
downregulated genes was not equally represented (p
value = .6 × 10−3). These results indicate that there are
more significantly downregulated than upregulated
genes in the 15q duplication neuronal cultures that did
not occur by chance alone.
Network analysis of differentially regulated Dup15q
genes
Since there was a larger set of genes differentially regu-
lated between Dup15q and control neurons (120) than
AS and controls (20), we focused on more detailed stud-
ies of the relationships among the proteins encoded by
genes up- or downregulated in the Dup15q vs control
neurons (Fig. 3a). Using STRING analysis, we identified
a core network of 23 proteins predicted to interact phys-
ically or through experimental evidence with the UBA52
protein providing the central link to several other pro-
teins mostly downregulated in Dup15q neurons vs con-
trols including the transcription factor FOXO1 and the
E2 ubiquitin ligase UBE2A (Fig. 3b). A second cluster of
three proteins that were significantly upregulated Fc ≥ +
2.8 fold was also identified that included the secreted
immune system factors CCL7, MMP3, and MMP1 (Fig.
3b). These cytokines may play a role in the differenti-
ation process from DPSC to DSPC-neurons, but subse-
quent analysis of peptide cytokine levels in the media of
mature DPSC neuronal cultures failed to recapitulate
the gene expression findings (data not shown).
Gene set enrichment analysis (GSEA) of differentially
regulated genes
Next, we looked for Gene Ontology (GO), Kyoto
Encyclopedia of Genes and Genomes (KEGG), and
TRANScription FACtor Database (TRANSFAC) en-
hanced subsets of differentially regulated genes using a
rank ordered gene lists for each binomial comparison
(rank ordered by p value lowest to highest) for each
comparison. To prioritize this data, we used GSEA soft-
ware that compares two gene expression data sets for
two phenotypes at a time to evaluate the presence of sig-
nificant enrichments for a particular molecular signature
from pre-defined Molecular Signature Database sets
(MSigDB) (for details, see the “Methods” section and
[38]). We looked for enrichments in KEGG, GO sub-
groups, and transcription factor binding site enrich-
ments (TRANSFAC) in DPSC neuronal cultures from
both AS and Dup15q individuals as compared to typical
controls (Fig. 4).
Perhaps, as expected for the AS deletion samples,
since very few genes were differentially regulated, there
were only a few pathway enrichment results that
approached the significance level (FDR q-value ≤ 25%),
considered a loose FDR cutoff value. Also of note, there
was a significant upregulation for genes that encode ster-
oid biosynthetic pathways (KEGG: “Steroid Biosynthesis”
FDR q-value ≤ 0.07% and “Steroid Hormone Biosyn-
thesis” FDR q-value≤ 1.8%; GO: “Steroid Metabolic
Process” FDR q-value≤ 24%) and downregulation for
genes involved in neural activity like “Chloride Chan-
nels” FDR q-value≤ 24% and “Ligand Gated Channels”
FDR q-value≤ 23%.
In the Dup15q sample analysis, we identified pathways
that were both significantly upregulated and downregu-
lated by this duplication in DPSC-neurons. Consistent
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with the finding that the cytokine CCL7 showed a > 2
fold increase in gene expression in Dup15q neurons vs
controls (adj. p value = 2.6 × 10−3), we found a significant
enrichment for cytokine/chemokine activity in the
Dup15q samples (FDR q-value ≤ 6% for GO: “Chemo-
kine Activity,” “Chemokine Receptor Binding,” “Cytokine
Activity,” and KEGG: Cytokine Cytokine Receptor Inter-
action FDR q-value ≤ 21%). There was also an increase
in Ras/Rho GTPase activity genes (GO: “RAS GTPase
activity” FDR q-value ≤ 25%, “Rho GTPase Activity” FDR
q-value ≤ 11%, and “GTPase Activator Activity” FDR q-
value ≤ 12%). Although not as pronounced as the 2.16
net enrichment score in “Steroid Biosynthesis” identified
in AS deletion neurons, there was still a significant 1.51
net enrichment score for these transcripts in the Dup15q
neurons as well.
Transcriptional downregulation between Dup15q neu-
rons and controls proved much more interesting. First,
there was a general downregulation for genes involved
in chromatin organization and biogenesis (GO: FDR q-
value ≤ 24%). Although they did not reach statistical
significance, there were other downregulated genes
involved in this process as well in the nominal p value
range of ≤ 1% (notably GO: “Chromatin Assembly and
Disassembly” and “Establishment or Maintenance of
Chromatin Architecture” nominal p values ≤ 0.05). Sec-
ond, there was a significant enrichment for genes poten-
tially regulated by transcription factors OCT1 and CEBP
Fig. 3 Global gene expression signatures for Dup15q and Angelman syndromes. a Unsupervised clustering heatmap signatures in DPSC neuronal
cultures for 15q Duplication vs controls (left), AS deletion vs controls (middle), and AS deletion vs 15q Duplication (right). Note that ~ 2/3 of the
transcripts went down in the DPSC neuronal cultures in 15q Duplication vs control and approximately 50% of the transcripts decreased in duplication
vs AS deletion DPSC-neurons. b STRING analysis of significantly different transcripts in DPSC neuronal cultures from 15q Duplication vs control analysis.
Colors of the circles represent the Log2 fold change in gene expression. Note the strong decrease in FOXO1 gene expression and the relationship of
this protein to other proteins in the significant network. Also note that three cytokines were significantly elevated at the transcript level (CCL7, MMP1,
and MMP3). c Venn diagram showing the significant overlap among genes upregulated in Dup15q postmortem cortex, idiopathic ASD postmortem
cortex, and the 1500 most significantly upregulated genes in DPSC neurons
Urraca et al. Molecular Autism  (2018) 9:6 Page 9 of 16
in the downregulated set (FDR q-value < 2.7% and < 12%
respectively). In addition, there was a nominal
enrichment for genes with FOXO1 regulatory binding
sites (p value = 7.0 × 10−3), a transcription factor encod-
ing gene which was significantly downregulated in the
Dup15q neurons (adj. p value = 3 × 10−3; Fc = − 3.5). The
complete list of GSEA enrichment results is available in
Additional file 1: Tables S1–S9.
We chose to validate by qRT-PCR putative FOXO1
regulated transcripts from the enrichment list which are
also associated with ASD (Additional file 1: Table S7).
Two genes, RORA and EPHB2, showed significantly de-
creased transcript expression in three unrelated idic15q
DPSC neuron lines vs controls (Fig. 5a). In addition,
FOXO1 showed a threefold decrease in gene expression
in idic15q vs controls consistent with the RNAseq
results. These results indicate a significant downregula-
tion for FOXO1 and two autism-associated genes with
FOXO1 binding sites (RORA and EPHB2) in DPSC-
derived neurons (Fig. 5a). Using an antibody against the
retinoid-related orphan receptor alpha (RORA) protein,
we found that this receptor is significantly downregu-
lated in neurons from an independent cohort of six
idic15q subjects vs neurotypical controls (Fig. 5b). These
results indicate that downregulation of the FOXO1 tran-
scription factor may be driving a portion of the ASD
phenotype in these individuals.
In addition, we performed quantitative Western blot
analysis for known neuronal differentiation markers in
both control and idic15 DPSC and DPSC-derived neu-
rons. We found that the neuronal markers MAP2 and
GABAA receptor were not expressed in DPSC but
Fig. 4 Summary of GSEA results at FDR q-value ≤ 0.25. The left side of table shows elevated chemokine/cytokine activity as well as both Rho and
Ras G-coupled protein receptor activity. Also of note, a trending increase in transcripts responsible for steroid hormone biosynthesis and a decrease in
transcripts involved in chromosomal organization. There is also a noted decrease in transcripts with OCT1 binding sites and a general increase
in transcripts that respond to serum response factor (SRF). In the case of AS DPSC neuronal cultures, there was a noted increase in steroid
metabolic processes and biosynthesis of steroid hormones (right table), but a general decrease in genes classified as having ligand gated and
chloride channel activity. A complete list of all GSEA analysis is available in Additional file 1: Tables S1–S9
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strongly expressed in DPSC-derived neurons regardless
of disease state and that the marker NLGN1 was
expressed in both DPSC and neurons (Fig. 6). Although
we did detect the post synaptic density marker PSD95 in
both control and idic15 neurons, we were unable to
quantify this result due to a cross reactive band in the
DPSC extracts (Additional file 2: Fig. S3). Finally, we de-
tected UBE3A protein in both control and idic15 neu-
rons as well as DPSC. Although the levels of UBE3A
protein did not reach significance, they did appear el-
evated in idic15 neurons as compared to control
DPSC-derived neurons (Fig. 6). These results indicate
that differentiation into cells expressing neuronal dif-
ferentiation markers is not inhibited in the disease
state in our system.
Gene expression in 15q duplication DPSC derived
neurons correlates to gene expression in Dup15q and
ASD postmortem cortex samples
As Dup15q syndrome is a common cause of ASD, which
is known to have a convergent molecular pathology [46],
we compared our gene expression results with postmor-
tem gene expression data in a recently published RNA-
seq study of both Dup15q and idiopathic ASD cases
compared to control brain [39] (Fig. 3c). Indeed, for
genes differentially expressed in the current study, we
found significant enrichments in the overlaps between
the genes most increased in expression in DPSC neurons
from Dup15q subjects and genes increased in expression
in both Dup15q syndrome and idiopathic ASD postmor-
tem cortices (Table 3). The overlaps were stronger, and
the functional enrichments more coherent, for Dup15q
than for idiopathic ASD. The only terms significantly
enriched (Bonferroni-corrected p < 0.05) in both the
upregulated Dup15q postmortem + upregulated
Dup15q DPSC comparison and the upregulated idio-
pathic ASD postmortem + upregulated Dup15q DPSC
comparisons were the rather broad “response to
oxygen-containing stimulus” and “response to organic
substance.” In contrast, genes in the intersection of
just the Dup15q comparisons had more interpretable
functional enrichments such as “structural constituent
of ribosome” (fold enrichment > 5; p = 3.45 × 10−20)
(Additional file 1: Table S8). Taken together, these
comparisons may suggest that Dup15q DPSC neurons
model at least some aspects of the gene expression
signature in postmortem cortex in both Dup15q syn-
drome and idiopathic ASD.
Fig. 5 Downregulation of FOXO1 regulated transcripts EPHB2 and RORA. a Using a list of putative FOXO1 regulated genes from TRANSFAC, we
looked for a set of genes known to be associated with ASD. While FOXP2, EN2, and ERG were not significantly downregulated by decreased
FOXO1 levels in an independent cohort of idic15 DPSC neurons, we found a significant decrease in four transcripts including EPHB2 and RORA
(as indicated by an increase in the average delta cross point values). Experiments were performed on six idic15 and six neurotypical controls
using three technical replicates. Significance was determined using Student’s t test. b Quantitative Western blot analysis indicates a significant
decrease in RORA protein levels (green) in idic15 samples vs controls. Experiments was performed three times on six samples per group.
Significance was determined using an unpaired Student’s t test across all data points for control vs idic15 for normalized RORA levels (normalized
to GAPDH in red)
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Discussion
DPSC are an excellent in vitro model to study gene ex-
pression and even protein expression changes in neuro-
genetic disorders. They are easily accessible through
noninvasive methods and can be shipped from long dis-
tances directly to the laboratory [30]. As with any in
vitro model, it is not perfect. In the near future, it will
be crucial to develop protocols to differentiate these cells
into specific neural subtypes coupled with extensive mo-
lecular and morphological characterization. That said, it
was recently shown that gene expression profiling in
neurons derived from iPSC is quite similar to neurons
from DPSC and that genes involved in neural develop-
ment and neurological disorders appear to be conserved
in terms of regulation [3]. In addition, the epigenetic
landscape of DPSC is more similar to embryonic stem
cells than other stem cell types used for neurogenetics
research, including iPSC [6]. DPSC-derived neurons in
culture are heterogeneous with a mixed of neurons and
glia cells. After maturation, there is an increase in neur-
onal markers, also demonstrated here in Fig. 6, and a de-
crease in glia markers (4,6); however, the proportion of
these cells can vary from culture to culture. In this
study, we took a new approach to the evaluation of gene
expression in neurons from individuals with two distinct
but genomically related neurodevelopmental disorders:
Angelman syndrome (AS) deletion (missing one copy of
the region), interstitial duplication of 15q11.2-q13.1 (a
Table 3 Changes in dup15q DPSC neurons overlap changes seen in postmortem cortex in both dup15q and idiopathic ASD




































In each cell is the fold enrichment of the overlap between the gene sets denoted by the corresponding row and column, and the two-tailed p value is given in
parenthesis (computed using the Fisher’s exact function in scipy.stats). Columns denote genes significantly differentially expressed in postmortem cortex between
either Dup15q and controls or idiopathic ASD and controls at a False Discovery Rate of 5%. Rows denote the 1500 most upregulated genes by p value and the
1500 most downregulated genes by p value in DPSC neurons comparing Dup15q DPSC neurons to control DPSC neurons (this was chosen to reduce type II error
given the limited power of the DESeq analyses on these sample sizes). This is repeated excluding all genes in the 15q11-13 cytobands (which also excludes some genes
flanking the duplicated region). The background was the intersection of genes expressed in Parikshak et al. and genes assigned a p value by DESeq in this study
a b
Fig. 6 Validation of neuronal differentiation markers in idic15 neurons. Quantitative Western blots were run using total protein extracted from
DPSC and DPSC-neuron cultures. a The western blots were probed with antibodies against the neuronal markers MAP2, GABAA, and NLGN1 as
well as for UBE3A protein levels (green) and normalized to levels of GAPDH loading control (red). b Quantification of Western blots. For all antibodies,
no significant difference was seen between control neurons and Idic15 DPSC-neurons indicating that both groups differentiate to neurons with similar
efficiency. In addition, both MAP2 and GABAA were only detected in differentiated DPSC-neurons. UBE3A was detected in all lanes but appears to be
expressed at higher levels in idic15 vs control DPSC-neurons, although these levels did not reach significance. Significance was determined by
unpaired t tests between DPSC and DPSC-neurons as well as across genotypes for a given cell type (N = 3)
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single extra copy of the region), and the isodicentric du-
plication of 15q (two extra copies of the region). Here,
we perform the first direct comparison of gene expres-
sion in 3-week-old live neurons from subjects with du-
plication vs deletion of the 15q region, both of which
can include autism spectrum disorder as part of the
phenotype [26, 47]. Previous studies indicated that gene
expression in 15q Duplication syndrome lymphoblasts
shared a general expression signature with both Fragile
X syndrome and idiopathic autism cases perhaps linked
by the CYFIPI gene, a gene we also found elevated in
DPSC neurons from idic(15) subjects [29]. In another
study, gene expression analysis using post mortem brain
tissue indicated that at least for genes within the dupli-
cated region (most notably GABRB3 and UBE3A) that
expression correlates with copy number [48]. Here, we
were able to confirm that copy number correlates sig-
nificantly with gene expression in the PWS/AS critical
region for both Angelman deletion and 15q duplication
syndromes (Table 2). The upward trend between copy
number and gene expression was significant for two im-
portant genes in neurons: UBE3A, a gene encoding the
HECT domain ubiquitin protein ligase responsible for
the key features of the AS phenotype [13], and a related
HECT domain protein HERC2, a protein which also has
been shown to physically interact with and functionally
enhance the activity of UBE3A [49, 50].
One limitation in interpreting these studies is the obser-
vation that gene expression of UBE3A is still detected in
3-week-old DPSC neuronal cultures that came from ma-
ternal AS deletion subjects. There may be several explana-
tions for this phenomena: (1) we were not able to use for
gene expression studies DPSC neuronal cultures matured
past ~ 5 weeks for gene expression studies because as
these cultures mature, the number live neurons decreases;
(2) DPSC are neural crest-derived cells from a lineage that
may not show imprinted gene expression for UBE3A
under the current culturing conditions, although this will
have a stronger effect on interpretation of the AS deletion
results than the Dup15q results since UBE3A duplications
are primarily maternal in origin and therefore UBE3A will
be expressed on the duplicated chromosome; (3) the pro-
portion of glial cells, which biallelically express UBE3A in
humans, to neurons is high in cultured DPSC neurons,
masking the mono-allelic expression of UBE3A in neurons
[51]. All of these possibilities will require further investiga-
tions using more mature DPSC neuron cultures, differing
culture conditions, and possibly a shift to the use of in-
duced dental pulp stem cells, if needed, as in a recent
ASD study [52].
The coordinated gene expression for UBE3A and
HERC2, located within the duplicated/deleted region on
15q, may have a significant impact on the phenotypes in
both AS and 15q duplication syndromes. In the case of
AS, the majority of individuals with this syndrome have
a deletion (70%), and among the deletion cases, the BP2-
BP3 deletion is more frequent (50%) but still includes
both UBE3A and HERC2 [14]. The other ~ 15% of
individuals have imprinting center defects, mutations in
maternal UBE3A, or paternal uniparental disomy. Indi-
viduals with a UBE3A mutations have a milder AS
phenotype with severe developmental delay, absence of
speech, inappropriate laughter and EEG abnormalities as
the most consistent findings and ataxia, epilepsy and
microcephaly can present as mild or even absent [53,
54], suggesting that loss of UBE3A expression in neu-
rons alone is not enough to recapitulate all aspects of
the AS phenotype. In fact, regulation of UBE3A by
HERC2 in deletion cases may enhance the phenotype
substantially and could certainly play a role in affecting
UBE3A function not only in non-imprinted tissues but
also in tissues where a preference for maternal-specific
expression has been found like heart and liver [55] or
even in parts of the brain where there is biallelic expres-
sion for UBE3A in GFAP positive cells lining the lateral
ventricles where neural stem cells develop [56]. In fact,
mutations in HERC2 can correlate with an
Angelman-like phenotype clearly implicating the phys-
ical interaction between HERC2 and UBE3A in some
aspect of the syndrome [57]. Given that HERC2 mu-
tations can also cause phenotypes on the autism
spectrum in some cohorts [58], we propose that the
elevated levels of gene expression for both UBE3A
and HERC2 found here in neurons from 15q Duplica-
tion syndrome subjects may have a more profound
impact on the autism phenotype in this disorder than
previously considered [7].
With regard to the 15q Duplication syndrome, this
study provides important clues to the underlying molecu-
lar etiology of the disorder in patient-derived neurons.
Gross downregulation of developmental transcription
factors such as FOXO1 (Fc = − 3.4), HAND2 (Fc = − 7.3),
and SOX11 (Fc = − 4.7) in 15q duplication neurons may
have significant pleiotropic effects on other genes regu-
lated by these transcription factors. We identified an en-
richment for the downregulation of genes with FOXO1
binding sites (nominal p value = 7X10− 3), for example,
that implicates genes regulated by FOXO1 in the syn-
drome. These genes include proteins involved in chroma-
tin reorganization as well as some specific genes involved
in regulating action potentials and dendrite formation.
Indeed, there is specific downregulation of both EPHB2
and RORA, two potential FOXO1 gene targets, at the
transcript level (Fig. 6a). The validation of downregulation
of RORA protein in an independent set of idic15q DPSC
neuron cultures vs controls lends further support to the
idea that these transcription factors, especially FOXO1,
may be the branch point for global downregulation of
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autism-associated nuclear receptor encoding genes like
RORA in Dup15q syndrome.
Although the identification of a transcription factor
like FOXO1 that may regulate several downstream ASD-
related transcripts is an important finding in this study,
perhaps more important was the finding that RORA
protein levels are significantly decreased in idic15q vs
control neurons. RORA transcript levels were previously
found to be significantly decreased in blood from ASD
vs control individuals [38]. Moreover, RORA, which is a
nuclear hormone receptor, has been shown in neuronal
cell lines to transcriptionally regulate ASD-associated
genes [59]. RORA is therefore an excellent candidate for
future molecular studies of autism in Dup15q syndrome,
a major portion of the phenotype [26].
Moreover, these transcription factors have now been
found to be dysregulated in other ASD samples. This
prompted us to investigate the correlation between our
gene expression data in 15q duplication neurons and a
recent study looking at gene expression changes in post-
mortem brain samples from both Dup15q syndrome and
idiopathic ASD cases. We found a clear overlap in 1/3 of
upregulated genes in all three comparisons (Table 3).
Contrasting DPSC-derived neurons to postmortem cor-
tical samples should be taken with caution as our in
vitro model does not consist exclusively of cortical neu-
rons. However, these comparisons are instructive for two
reasons: firstly, it shows that DPSC-derived neurons in
Dup15q syndrome recapitulate the molecular changes
seen in postmortem Dup15q and idiopathic autism
brain, even and especially outside the 15q region and
that this may therefore be a model with a tractable mo-
lecular handle to learn about neurobiology in idiopathic
ASD more generally; secondly, it demonstrates that at
least some components of the convergent molecular sig-
nature in autism brains are inherent to the local neuro-
biology and are not downstream neurological responses
to growing up autistic in a neurotypical world.
It is perhaps no surprise that gene expression in AS
neurons did not differ significantly from control neurons
for many genes since the primary gene expected to con-
tribute to pathogenesis in AS encodes an E3 ubiquitin
ligase that targets other proteins for degradation or
other cellular functions at the protein level. Several po-
tential protein targets contributing to pathogenesis have
been identified over the years, but no targets have yet
emerged that can clearly explain all of the neurological
phenotypes in AS on their own [16, 19, 44, 50, 60, 61]. It
has been known for some time, however, that UBE3A
can act as a transcriptional co-activator of steroid hor-
mone receptors [22], and our own work in Drosophila
indicates that Dube3a expression can regulate gene ex-
pression for GTP cyclohydrolase I leading to increased
or decreased dopamine in the brains of flies [15]. Here,
we show that patient-derived DPSC neuronal cultures
do show aberrant gene expression for 23 genes com-
pared to controls. Of these, the one gene that does seem
consistent with other UBE3A studies is the CRY2 gene
(adj. p value = 2 × 10−2; Fc = − 2.0). CRY2 is a circadian
clock gene, and circadian rhythm defects have been
found in both fly and mouse models of AS [44, 45]. It
remains to be seen if this regulation of CRY2 is contrib-
uting to these circadian defects, however, and the limited
number of transcriptional changes found in the AS neu-
rons seems to imply that transcriptional regulation of
genes other than UBE3A is not a key contributor to the
pathogenesis of AS in neurons.
Conclusions
In conclusion, this study demonstrates that DPSC-derived
neurons express several neuronal differentiation markers
(MAP2, GABAA, NLGN1, and PSD95) and may prove a
useful tool for the study of neurogenetic disease. Here, we
demonstrated that global gene expression in immature
neurons is not significantly altered in AS deletion DPSC
neurons but that changes in gene expression found in the
15q duplication DPSC neurons indicate that this particu-
lar duplication results in downregulation, rather than up,
for genes located outside of the Dup15q critical region
through transcription factors like HAND2, OCT1, and
FOXO1 and subsequently the ASD associated transcrip-
tional activator RORA. Finally, we found more changes in
gene expression in Dup15q than AS cell lines, implying
that the mechanism of AS may be primarily through the
degradation of UBE3A protein substrates as previously
proposed in other studies.
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Additional file 1: Tables S1–S9. Complete GSEA analysis for all samples
and FOXO1 and functional enrichment analysis of ASD brain vs Dup15q
DPSC neurons. S9 is a table of primers used for qRT-PCR. (XLSX 68 kb)
Additional file 2: Figure S1. Copy number and breakpoint analysis by
FISH. Examples of each cell line are shown. All cell lines were analyzed
with NIPA1 + SNRPN or TRPM1 + SNRPN. At least 15 cell preparations
were analyzed for each line to determine the breakpoints and copy
numbers. Note, DPSC line TP-041 is an interstitial duplication line with
three copies of the BP2-BP3 region (green signals) but only one copy of
the BP1-BP3 or BP4-BP5 regions (red signals). Fig. S2 Boxplots for specific
genes of interest mentioned in the text. These are the RPKM averages
across all three biological replicates for DPSC and DPSC neuronal cultures
and for control (red), Dup15q (blue), and AS (green) for each gene of
interest. Error bars are standard deviation. Fig. S3 PSD95 staining of DPSC
and DPSC-derived neurons. A band correlating to PSD95 is seen in the
DPSC-neuronal cultures. Unfortunately, a cross-reactive band also present
in the α-goat secondary alone blot interfered with the signal for PSD95
in DPSC alone making quantification impossible (top versus middle lane).
GAPDH was used as a loading control. (PDF 3128 kb)
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